Cresco Labs (CRLBF) Other Non Operating Income (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Other Non Operating Income came in at $960000.0 in Q1 2026, up 176.66% YoY from $347000.0 in Q1 2025, and down 63.96% on a QoQ basis from $2.7 million in Q4 2025.
Cresco Labs (CRLBF) Other Non Operating Income (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Other Non Operating Income data on file, last reported at $960000.0 in Q1 2026.
- Quarterly Other Non Operating Income rose 176.66% year-over-year to $960000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.6 million (up 83.06% YoY) and the FY2025 annual result came in at -$11.2 million, up 82.38% from the prior year.
- Other Non Operating Income retreated to $960000.0 in Q1 2026, from $2.7 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $14.8 million in Q3 2022 to a low of -$59.5 million in Q2 2024.
- A 5-year average of -$2.9 million and a median of $959000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income surged 752.85% — and 2025, when it tumbled 267140.0%.
- Tracing CRLBF's Other Non Operating Income over 5 years: stood at $2.5 million in 2022, then dropped by 9.64% to $2.3 million in 2023, then slumped by 243.63% to -$3.3 million in 2024, then soared by 181.42% to $2.7 million in 2025, then plunged by 63.96% to $960000.0 in 2026.
- The last three Other Non Operating Income figures came in at $960000.0 (Q1 2026), $2.7 million (Q4 2025), and -$13.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Cresco Labs | 297.83 Mn | 233.72 Mn | 86.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 960,000.00 |
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | -13.36 Mn |
| Jun 30, 2025 | -836,000.00 |
| Mar 31, 2025 | 347,000.00 |
| Dec 31, 2024 | -3.27 Mn |
| Sep 30, 2024 | -5,000.00 |
| Jun 30, 2024 | -59.51 Mn |
| Mar 31, 2024 | 856,000.00 |
| Dec 31, 2023 | 2.28 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Jun 30, 2023 | 1.04 Mn |
| Mar 31, 2023 | 959,000.00 |
| Dec 31, 2022 | 2.52 Mn |
| Sep 30, 2022 | 14.80 Mn |
| Jun 30, 2022 | 4.68 Mn |
| Mar 31, 2022 | -6.77 Mn |
| Dec 31, 2021 | 10.91 Mn |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 12.73 Mn |